首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1629326

神經血管栓塞設備市場，按產品、最終用途、國家和地區 - 2025-2032 年全球行業分析、市場規模、市場佔有率和預測

Neurovascular Embolization Devices Market, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2024年12月04日 | 出版商:

AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2024年神經血管栓塞設備市場規模為15.616億美元，2025年至2032年複合年成長率為8.90%。

神經血管栓塞器材市場-市場動態

腦中風和動脈瘤病例增加

在整個預測期內，腦中風和動脈瘤病例數量的增加預計將推動全球神經血管栓塞設備市場的擴張。例如，世界中風組織聲稱，中風已經達到流行的程度。今年將有超過 1,220 萬人首次中風，預計將有 650 萬人因此死亡，這意味著四分之一的 25 歲以上成年人中就有 1 人會在一生中的某個階段發生中風。在全球範圍內，超過 1.1 億人曾在一生中的某個時期患過中風。儘管中風的盛行率隨著年齡的成長而急劇上升，但超過 60% 的中風發生在 70 歲以下的人群中，超過 16% 的中風發生在 50 歲以下的人群中。此外，英格蘭國家醫療服務體系 (NHS England) 估計，每年英格蘭每 12,500 人中就有 1 人患有腦動脈瘤破裂。此外，腦動脈瘤基金會估計，每年有超過 600 萬美國人患有腦動脈瘤，英國有超過 3.0% 的人患有腦動脈瘤。此外，NIH報告稱，全球範圍內腦動脈瘤的盛行率約為3.2%，標準年齡為50歲，整體性別比例為1:1。 50 歲以後，這一比例變化很大，女性比例不斷上升，接近 2:1。這被認為是因為循環雌激素水平較低導致血管組織的膠原蛋白範圍減少。

神經血管栓塞設備市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2025-2032）每年將以 8.90% 左右的複合年成長率成長

根據產品細分，預計栓塞彈簧圈在 2024 年將佔據最大市場佔有率

根據最終用途細分，到 2024 年，醫院將成為領先類別

按地區分類，北美是 2024 年的主要收入來源

神經血管栓塞設備市場-細分分析：

全球神經血管栓塞設備市場根據產品、最終用途和地區進行細分。

依產品，市場分為液態栓塞劑、栓塞彈簧圈、動脈瘤夾、分流裝置等。 2024 年，市場由栓塞彈簧圈類別主導。將稱為栓塞彈簧圈的複雜鉑裝置插入動脈中以導致血栓形成。這些線圈成功地阻斷了動脈瘤和其他血管異常，降低了破裂和隨後出血的可能性。由於它們對各種解剖併發症的適應性，它們非常受歡迎。經過不斷的研發努力，生物活性和可拆卸彈簧圈的開發提高了該領域的功效和安全性。此外，神經血管治療中最重要的進展之一是液體栓塞的使用。

根據最終用途，市場分為醫院、專科診所和其他。 2024年，醫院類別佔據主導市場。醫院因其先進的技術、龐大的基礎設施和高素質的醫務人員而成為神經血管栓塞等尖端醫療治療的主要場所。憑藉最新的成像設備和介入套件，這些設施通常擁有專用的神經介入裝置，可實現準確的診斷和客製化護理。在醫院環境中，擁有合格的神經外科醫生、介入放射科醫生和神經科醫生可以保證患有動脈瘤和動靜脈畸形等疾病的患者得到全面的多學科護理。

神經血管栓塞設備市場-地理洞察

2024年，北美在全球神經血管栓塞器械市場佔據主導地位。北美，尤其是美國和加拿大，神經血管栓塞裝置的市場很大。這些國家的神經血管疾病發生率很高，醫療保健系統完善，醫療費用不斷增加。政府措施和製造商研發 (R&D) 支出的增加對區域市場的成長產生了重大影響。此外，主要行業參與者推出新產品以使其產品線多樣化，也有助於該行業的成長。例如，印度美敦力於2022年6月生產的第四代導流器Pipeline Vantage with Shield Technology，具有CE標誌，用於腦動脈瘤的血管內治療。

然而，在整個預測期間，亞太地區預計複合年成長率最快。神經系統問題的日益普及、技術突破以及目標疾病負擔的增加是造成這種情況的部分原因。主要參與者的存在和不斷成長的醫療保健成本是推動該地區擴張的兩個進一步因素。由於主要參與者的區域擴張以及亞太地區尚未開發的巨大前景，預計該市場在預測期內也將成長更快。該地區神經血管栓塞裝置市場的三個最大供應商是中國、印度和日本。

神經血管栓塞設備市場-競爭格局：

神經血管栓塞裝置領域的主要公司包括美敦力公司、史賽克公司、強生公司、B. Braun Melsungen AG.、Integra LifeSciences Corporation 等。神經血管栓塞裝置的主要生產商正在集中精力進行併購，以使其產品線多樣化。在醫院和其他機構，企業正在舉辦會議和培訓課程，向外科醫生和從業人員介紹新型神經血管栓塞裝置。此外，成長舉措，包括新產品發布、監管批准、擴張、夥伴關係、收購和合作，是主要業務的主要重點。例如，Terumo Corporation 旗下神經血管公司 MicroVention, Inc. 於 2023 年 7 月表示，其血管內裝置 WEB 已發布 5 年監測資料。為了使動脈瘤栓塞技術更適應不同大小和類型的動脈瘤，他們還包括兩種新尺寸（SL 7x2 和 SL 6x2）。該產品在聖地牙哥 SNIS 2023 的 615 號攤位展出。在整個預測期內，由於這些發展，對神經血管栓塞裝置的需求將會增加。

近期發展

2023 年2 月：Shape Memory Medical Inc. 報告了第一例在德國接受治療的患者，這是該公司即將對其用於周邊血管栓塞的IMPEDE 和IMPEDE-FX 栓塞進行多中心登記調查的EMBO 後市場監測登記的一部分。

2022 年 7 月：在多倫多參加第 19 屆神經介入外科學會 (SNIS) 年會時，設計創新神經血管設備的 Rapid Medical 公司獲得了 FDA 510(k) 許可，將 TIGERTRIEVER 13 用於治療大動脈閉塞。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美神經血管栓塞裝置主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按產品）
- 北美市場規模和預測（按最終用途）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲神經血管栓塞裝置主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模和預測（按產品）
- 歐洲市場規模和預測（按最終用途）
- 德國
- 法國
- 義大利
- 西班牙
- 英國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區神經血管栓塞器械主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按產品）
- 亞太地區市場規模和預測（按最終用途）
- 印度
- 中國
- 韓國
- 日本
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲神經血管栓塞裝置主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按產品）
- 拉丁美洲市場規模和預測（按最終用途）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲神經血管栓塞裝置主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按產品）
- 中東和非洲市場規模和預測（按最終用途）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 10 章：主要供應商分析 - 神經血管栓塞器械產業

競爭儀表板
公司簡介
- Medtronic plc
- Stryker Corporation
- Johnson & Johnson Inc.
- B. Braun Melsungen AG.
- Integra LifeSciences Corporation
- Lepu Medical Technology (Beijing) Co.
- Terumo Corporation
- Acandis GmBH
- Phenox GmBH
- Shape Memory Medical Inc.
- Others

第 11 章：360 度分析師視角

第 12 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4485

REPORT HIGHLIGHT

Neurovascular Embolization Devices Market size was valued at US$ 1,561.6 Million in 2024, expanding at a CAGR of 8.90% from 2025 to 2032.

Neurovascular embolization devices prevent or limit blood flow to unwanted vascular abnormalities. Neurovascular embolisation devices include aneurysm clips, liquid embolic systems, flow diversion stents, embolisation coils, and intravascular flow disruptors. A stroke occurs when the blood supply to the brain is disrupted, resulting in oxygen deprivation, brain damage, and diminished function. The most frequent cause is clots in the arteries that provide blood to the brain. Hemorrhage, which happens when blood seeps into the brain from a ruptured vessel, may even be the reason. Memory, cognitive, and linguistic issues, as well as partial paralysis, are among the long-term effects of a stroke. The increasing rates of brain stroke and aneurysms, the rise in product authorizations, the positive outcomes of research, market developments like mergers and acquisitions, the introduction of new products, and growing awareness are some of the factors that are expected to drive growth in the global market for neurovascular embolization devices over the forecast period. The growing number of cases and research funding are also expected to help the worldwide market's expansion over the course of the projected period.

Neurovascular Embolization Devices Market- Market Dynamics

Increased Brain Stroke and Aneurysm Cases

Throughout the forecast period, the rising number of brain stroke and aneurysm cases is anticipated to propel the expansion of the global neurovascular embolization devices market. The World Stroke Organization, for example, claims that epidemic proportions of stroke have already been reached. Over 12.2 million individuals are likely to have their first stroke this year, and 6.5 million are expected to die as a result, meaning that 1 in 4 adults over 25 will have a stroke at some point in their lives. Worldwide, more than 110 million people have had a stroke at some time in their life. Over 60% of strokes occur in those under 70, and over 16% occur in people under 50, despite the fact that the prevalence of stroke rises sharply with age. Additionally, NHS England estimates that 1 in 12,500 people in England suffer from a burst brain aneurysm annually. In addition, the Brain Aneurysm Foundation estimates that over 6.0 million Americans suffer from brain aneurysms each year, and over 3.0% of persons in the United Kingdom suffer from one. Moreover, the NIH reports that the prevalence of cerebral aneurysms is approximately 3.2% worldwide, with a standard age of 50 and a gender ratio of 1:1 overall. After age 50, this ratio varies significantly, with a growing female predominance that closes at 2:1. This is thought to be because lower levels of circulating estrogen cause the collagen range of the vascular tissue to diminish.

Neurovascular Embolization Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2025-2032)

Based on product segmentation, the embolic coils were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading category in 2024

On the basis of region, North America was the leading revenue generator in 2024

Neurovascular Embolization Devices Market- Segmentation Analysis:

The Global Neurovascular Embolization Devices Market is segmented on the basis of Product, End Use, and Region.

On the basis of product, the market is segregated into Liquid Embolic Agents, Embolic Coils, Aneurysm Clips, Flow Diversion Devices, and Others. In 2024, the market was dominated by the embolic coils category. Complex platinum devices called embolic coils are inserted into blood arteries to cause clots to form. These coils successfully block aneurysms and other vascular anomalies, lowering the possibility of rupture and ensuing bleeding. Because of their adaptability to a variety of anatomical complications, they are very popular. The development of bioactive and detachable coils has improved the field's efficacy and safety as a result of continuous research and development efforts. Furthermore, one of the most important developments in neurovascular treatments is the use of liquid emboli.

Based on end use, the market is divided into Hospitals, Specialty Clinics, and Others. In 2024, the hospitals category held a dominant market share. Hospitals are the main locations for cutting-edge medical treatments like neurovascular embolization because of their sophisticated technology, large infrastructure, and highly qualified medical personnel. With the newest imaging equipment and interventional suites, these facilities frequently have dedicated neuro interventional units that enable accurate diagnosis and customized care. In hospital settings, having qualified neurosurgeons, interventional radiologists, and neurologists guarantees patients with disorders like aneurysms and arteriovenous malformations full, multidisciplinary care.

Neurovascular Embolization Devices Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Neurovascular Embolization Devices. The market for neurovascular embolization devices is substantial in North America, particularly in the United States and Canada. These countries have high rates of neurovascular diseases, sophisticated healthcare systems, and growing medical expenses. The growth of the regional marketplace is significantly impacted by the heightened government initiatives and manufacturer research and development (R&D) spending. Additionally, the introduction of new products by major industry players to diversify their product lines contributes to the growth of the sector. For instance, India Medtronic's fourth-generation flow deflector, the Pipeline Vantage with Shield Technology, which has a CE mark, was created in June 2022 for endovascular treatment of cerebral aneurysms.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The increasing prevalence of neurological problems, technical breakthroughs, and the growing burden of target diseases are some of the causes of this. Key players' presence and growing healthcare costs are two further factors fueling the region's expansion. The market is also expected to grow more rapidly in the forecast period due to the regional expansion of major players and significant unexplored prospects in Asia Pacific. Three of the biggest suppliers to the neurovascular embolization device market in the area are China, India, and Japan.

Neurovascular Embolization Devices Market- Competitive Landscape:

Key companies in the neurovascular embolization devices are Medtronic plc, Stryker Corporation, Johnson & Johnson Inc., B. Braun Melsungen AG., Integra LifeSciences Corporation, and others. The primary producers of neurovascular embolization devices are concentrating on mergers and acquisitions in order to diversify their product lines. In hospitals and other institutions, businesses are holding conferences and training sessions to inform surgeons and practitioners about the new neurovascular embolization devices. Furthermore, growth initiatives, including new product releases, regulatory approvals, expansions, partnerships, acquisitions, and collaborations, are the main emphasis of the major businesses. For instance, MicroVention, Inc., a neurovascular company under Terumo Corporation, stated in July 2023 that its intravascular device, WEB, has released 5-year monitoring data. In order to make the Aneurysm Embolization Technology more adaptable to aneurysms of different sizes and types, they also included two new sizes (SL 7x2 and SL 6x2). The product is on display at Booth 615 at SNIS 2023 in San Diego. Throughout the projection period, the demand for neurovascular embolization devices will rise as a result of these developments.

Recent Development

February 2023: The first patient treated in Germany as part of the EMBO-Post Market Surveillance Registry, the company's upcoming multicenter registry investigation of its IMPEDE and IMPEDE-FX Embolization Plugs when used for peripheral vascular embolization, was reported by Shape Memory Medical Inc., a manufacturer of shape memory polymers for the peripheral and neurovascular markets.

July 2022: While attending the 19th Annual Conference of the Society of Neurointerventional Surgery (SNIS) in Toronto, Rapid Medical, a company that designs innovative neurovascular devices, received FDA 510(k) permission for TIGERTRIEVER 13 for major artery occlusions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Medtronic plc
Stryker Corporation
Johnson & Johnson Inc.
B. Braun Melsungen AG.
Integra LifeSciences Corporation
Lepu Medical Technology (Beijing) Co.
Terumo Corporation
Acandis GmBH
Phenox GmBH
Shape Memory Medical Inc.
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Liquid Embolic Agents
Embolic Coils
Aneurysm Clips
Flow Diversion Devices
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospitals
Specialty Clinics
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Neurovascular Embolization Devices Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Neurovascular Embolization Devices Market Snippet by Product
- 2.1.2. Neurovascular Embolization Devices Market Snippet by End Use
- 2.1.3. Neurovascular Embolization Devices Market Snippet by Country
- 2.1.4. Neurovascular Embolization Devices Market Snippet by Region
2.2. Competitive Insights

3. Neurovascular Embolization Devices Key Market Trends

3.1. Neurovascular Embolization Devices Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Neurovascular Embolization Devices Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Neurovascular Embolization Devices Market Opportunities
3.4. Neurovascular Embolization Devices Market Future Trends

4. Neurovascular Embolization Devices Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Neurovascular Embolization Devices Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Neurovascular Embolization Devices Market Landscape

6.1. Neurovascular Embolization Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Neurovascular Embolization Devices Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Liquid Embolic Agents
- 7.1.3. Embolic Coils
- 7.1.4. Aneurysm Clips
- 7.1.5. Flow Diversion Devices
- 7.1.6. Others

8. Neurovascular Embolization Devices Market - By End Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
- 8.1.2. Hospitals
- 8.1.3. Specialty Clinics
- 8.1.4. Others

9. Neurovascular Embolization Devices Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Neurovascular Embolization Devices Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Neurovascular Embolization Devices Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.7. France
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Neurovascular Embolization Devices Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Neurovascular Embolization Devices Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Neurovascular Embolization Devices Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Neurovascular Embolization Devices Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Medtronic plc
- 10.2.2. Stryker Corporation
- 10.2.3. Johnson & Johnson Inc.
- 10.2.4. B. Braun Melsungen AG.
- 10.2.5. Integra LifeSciences Corporation
- 10.2.6. Lepu Medical Technology (Beijing) Co.
- 10.2.7. Terumo Corporation
- 10.2.8. Acandis GmBH
- 10.2.9. Phenox GmBH
- 10.2.10. Shape Memory Medical Inc.
- 10.2.11. Others